Atlantic Systems: Powerful and Feature-Rich POS for the Liquor Market

Atlantic Systems: Powerful and Feature-Rich POS for the Liquor Market

Follow Atlantic Systems on :

To establish and thrive in any niche area with a unique value proposition, a company needs all the hands-on experience possible. Being one of the most highly regulated and niche sectors in the retail industry, the liquor market is subject to state-wise variances in legislation. And among the various challenges faced by liquor store managers and retail chain executives, the lack of a POS system that is fine-tuned with the ever-changing laws of selling liquor across the U.S. is the most prominent. Enter Atlantic Systems, a New Jersey-based POS provider that has developed a product based on the expertise that its founders accumulated during their time as liquor store managers in the late 1970s. Today, with its 30-year experience of serving liquor retailers, the company offers a POS solution that is developed keeping the current needs of the industry in mind. “Atlantic Systems builds a symbiotic relationship with its clients, to design and augment POS systems based on market requirements and customer feedback,” says AJ Stetz, the company’s president.

Unlike its contemporaries, the company’s POS incorporates diverse features such as internal gift card processing, seamless linking between POS and client website, and more. In addition, the POS provider offers a mobile application that allows business owners to monitor the operations of their store or retail chain in real time. Above all, Atlantic Systems has developed its POS with a large number of integration points, which the company leverages to offer easy-to-use solutions to independent stores and retail liquor chains. One such product is Spirits Mobility, which allows a store owner to check stock on the floor in real time, create labor lists, and make purchase orders. Additionally, Atlantic Systems has developed other modules that allow the POS product’s integration with delivery services like Instacart, as well as in-store kiosks to enable the execution of tasks such as scanning prices and building customer lists.
Apart from the all-inclusive set of functionalities of its POS software, Atlantic Systems also offers hardware and implementation services to ensure efficient utilization. Further, in cases where a client lacks the sufficient data needed to run a POS, Atlantic Systems leverages its master database—comprising data pertaining to over 120,000 products. The company also offers a yearly support contract, which gives customers technical support, periodic software updates, and reports on the market shifts.

To highlight the effectiveness of Atlantic Systems’ POS, Stetz cites an incident about a liquor business owner who stopped using the company’s offering and transitioned to another POS in the market, only to return to Atlantic Systems five years later. Stetz takes pride in such customer stories because it perfectly illustrates the unique position his company holds in the highly competitive liquor retail space. “We try to differentiate ourselves from the competition by providing more interaction channels between businesses and their customers to drive loyalty,” adds Stetz.

With an aim to provide its POS and complementary services to more store managers in the U.S., Stetz is planning to expand Atlantic Systems’ existing clientele into more states including Illinois, Missouri, and California. From a product standpoint, the company is currently developing an integrated security solution suite, which covers the installation of surveillance cameras that are linked to Atlantic Systems’ POS solution and mobile application. This new offering will also provide daily and weekly reports detailing any security incidents. Additionally, the company is introducing integration with in-store digital signage to reflect pricing changes made in the system along with providing electronic data exchange to enable automated purchase order entry. “We are always on the forefront of technology to improve our POS for it to be in tandem with the emerging trends,” concludes Stetz.

Atlantic Systems News

Covance and Definiens Collaborate to Integrate Digital Pathology into Precision Medicine Design and Development

BURLINGTON, N.C. & MUNICH - LabCorp® (NYSE: LH), a leading global life sciences company, and Definiens®, a pioneer in artificial intelligence (AI) based image analysis, announced a strategic collaboration to improve global development of precision medicine. The collaboration, between Definiens and LabCorp’s Covance drug development business, will enable seamless integration of digital pathology with clinical-trial design and tissue-based testing solutions, resulting in a faster and more rigorous approach to biomarker validation and companion diagnostic co-development.

Companion diagnostics are used in conjunction with targeted drugs and therapies to identify patients who are likely to benefit from a specific treatment regimen or who may have increased risk for certain side effects. The companies expect the first application of these processes will be in oncology, particularly immuno-oncology.

LabCorp and Covance have been involved in the development of drugs and their associated companion diagnostics for more than 20 years and have supported approximately two-thirds of all FDA-approved companion diagnostics. Definiens leverages machine learning and deep-learning to comprehensively profile the tumor microenvironment and create unique patient phenotypic profiles. Its digital pathology applications enable biopharma companies to make more informed decisions regarding their oncology and immuno-oncology pipelines.

The collaboration will initially focus on multiplex immunohistochemistry (IHC) and in situ hybridization (ISH) applications in early-stage clinical programs, which allow researchers to obtain significantly more information from a single sample than with other standard methods. This approach is designed to enable the therapy to advance more quickly to pivotal clinical trial scale studies. Terms of the agreement have not been disclosed.

“This collaboration unites Definiens’ ground-breaking technology and innovation with Covance’s extensive experience in biomarker identification and companion diagnostics development,” said John Ratliff, CEO, Covance. “Together, we can accelerate the pace of drug development, delivering the transformative potential of oncology therapies – and immuno-oncology in particular – to patients around the globe faster and more efficiently than ever before.”

“Based on years of AI development, Definiens Tissue Phenomics® is recognized as the premier technology for characterizing the tumor microenvironment for immuno-oncology applications,” said Thomas Heydler, CEO, Definiens. “We are very excited to partner with Covance, the world leader in companion diagnostics, to demonstrate the power of Tissue Phenomics as an integral part of CDx development for clinical trials worldwide.”